Insulin-like growth factor (IGF) axis in cancerogenesis

A Kasprzak, W Kwasniewski, A Adamek… - … Research/Reviews in …, 2017 - Elsevier
Determination of the role of insulin-like growth factor (IGF) family components in
carcinogenesis of several human tumors is based on numerous epidemiological and pre …

[HTML][HTML] Mechanism and recent updates on insulin-related disorders

S Kumar, S Senapati, N Bhattacharya… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Insulin, a small protein with 51 amino acids synthesized by pancreatic β-cells, is crucial to
sustain glucose homeostasis at biochemical and molecular levels. Numerous metabolic …

Notch transduction in non-small cell lung cancer

A Sharif, A Shaji, M Chammaa, E Pawlik… - International Journal of …, 2020 - mdpi.com
The evolutionarily-conserved Notch signaling pathway plays critical roles in cell
communication, function and homeostasis equilibrium. The pathway serves as a cell-to-cell …

Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R

H Xu, C Liu, Y Zhang, X Guo, Z Liu, Z Luo… - Acta Biochim …, 2014 - academic.oup.com
Multiple myeloma (MM) is the most common cause of death from hematological malignancy
worldwide, and recent studies have revealed that let-7b-5p can play an inhibitory role in …

Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells

Y Lee, Y Wang, M James, JH Jeong… - Molecular …, 2016 - Wiley Online Library
Non‐small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor
(EGFR) mutation have benefited from treatment of reversible EGFR tyrosine kinase inhibitors …

Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression

Z Huang, M Zhang, G Chen… - International …, 2019 - spandidos-publications.com
Although important progress has been made in elucidating the role of the tumor
microenvironment in the development of bladder cancer, little is currently known regarding …

Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer

F Wang, F Meng, SCC Wong… - Therapeutic …, 2020 - journals.sagepub.com
Background: Non-small cell lung cancer (NSCLC) patients with an epidermal growth factor
receptor (EGFR) mutation often initially respond to EGFR tyrosine kinase inhibitor (EGFR …

Inhibition of COX-2 and EGFR by melafolone improves anti-PD-1 therapy through vascular normalization and PD-L1 downregulation in lung cancer

H Tang, Y Liu, C Wang, H Zheng, Y Chen, W Liu… - … of Pharmacology and …, 2019 - ASPET
Checkpoint blockade therapy has been proven efficacious in lung cancer patients. However,
primary/acquired resistance hampers its efficacy. Therefore, there is an urgent need to …

Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in …

L Chao, H Yi-Sheng, C Yu, Y Li-Xu, L Xin-Lan… - Lung cancer, 2014 - Elsevier
Background A new histological classification by the International Association for the Study of
Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) …

Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)

AJ Piper, JL Clark, J Mercado-Matos… - PloS one, 2019 - journals.plos.org
The insulin-like growth factor-1 (IGF-1) signaling pathway has been implicated in non-small
cell lung cancer (NSCLC) outcomes and resistance to targeted therapies. However, little is …